U.S., Aug. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07098520) titled 'Biomarkers of Steatohepatitis in Type 2 Diabetes Patients' on April 27, 2024.

Brief Summary: The aims of the study are to identify a subgroup of type 2 diabetics at risk of developing and progressing to non-alcoholic steatohepatitis (NASH), to correlate clinical and laboratory parameters with sonographic and elastographic findings in order to pinpoint indicators of liver fibrosis (NASH), and to facilitate targeted screening and intensified management of type 2 diabetes mellitus to prevent NASH complications.

Study Start Date: Sept. 01

Study Type: OBSERVATIONAL

Condition: Diabetes Steatosis of Liver

Intervention: OTHER: No inter...